XWELL Inc.
Diagnostics & Research
Healthcare
XWEL
4.82 M shares
NASDAQ US
traded
14 Jan 2025
listed
no
open
1.36
52 week high
2.52
high
1.39
52 week low
1.27
low
1.34
growth
-7.43 %
previous Close
1.36
P/E ratio
market cap
8.25 M
div yield
0
usd
Sep 2024
qoq
revenue
8.42 M
-9.27 %
net incoming
-4.75 M
-137.98 %
eps
0.00 %
-106.56 %
eps surprise
0.00 %
net profit margin
-56.40 %
-34.00 %
operating incoming
-4.77 M
-151.93 %
net change in cash
-1.05 M
-195.73 %
cash on hand
4.37 M
-19.44 %
cost of revenue
6.37 M
2.68 %
top top